Halozyme Therapeutics, Inc. (HALO) Reports Fourth Quarter and Year End 2012 Financial Results
2/26/2013 6:13:17 AM
SAN DIEGO, Feb. 25, 2013 -- /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the fourth quarter and year ended December 31, 2012.
"2012 was another productive year marked by key partner regulatory filings in Europe, as well as our establishment of a new collaboration with Pfizer," said Gregory I. Frost, Ph.D., President and Chief Executive Officer, Halozyme. "These advancements, coupled with the continued progress of our own pipeline products, leave Halozyme well-positioned for continued growth in 2013."